Generics - Production, Markets & Marketing

Filter

Popular Filters

Indian govt plans to support a competitive pharma sector, especially for SMEs

Indian govt plans to support a competitive pharma sector, especially for SMEs

14-04-2014

In a bid to strengthen the existing infrastructure facilities and to enable the Indian pharmaceutical…

Asia-PacificGenericsIndiaMarkets & MarketingPoliticsProduction

Study produces map of pharma industry and API production in Brazil

Study produces map of pharma industry and API production in Brazil

28-03-2014

Brazil is failing to produce the number of active pharmaceutical ingredients in order to produce the…

BrazilGenericsMarkets & MarketingProductionSouth America

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

27-01-2014

Brazil's Development Bank (BNDS) plans to invest up to 10 billion real ($4.2 billion) in the production…

BiotechnologyBrazilFinancialGenericsHypermarcasMarkets & MarketingProductionSanofiSouth America

Brazil to produce atazanavir to supply SUS demand; strong pharma growth forecast for 2014

15-01-2014

Following the Official Gazette market application filling for the drug atazanavir sulfate, an HIV protease…

Anti-viralsatazanavirBrazilBristol-Myers SquibbFiocruzGenericsMarkets & MarketingPharmaceuticalProductionSouth America

Less than 30% of drugs in Nigeria made locally

15-07-2013

Last week, the Director General, of Nigeria's National Agency for Foods, Drugs Administration and Control,…

GenericsMarkets & MarketingPharmaceuticalProductionRest of the World

Italy's Chiesi eyes Russian expansion

30-04-2013

Privately held Italian drugmaker Chiesi Farmaceutici is considering a massive expansion into the Russian…

Chiesi FarmaceuticiEuropeGenericsMarkets & MarketingPharmstandardProductionRespiratory and Pulmonary

Argentina's pharma market to almost triple over one decade, says GlobalData

24-04-2013

Argentina's pharmaceutical market is expected to grow from a value of around $5.6 billion in 2012 to…

GenericsMarkets & MarketingPatentsPharmaceuticalProductionRegulationSouth America

Both biosimilar and reference biologics companies must consider product-specific and regional strategies

09-04-2013

With sales forecasted to exceed $16.8 billion by 2021, manufacturers competing in the biosimilars market…

BiotechnologyGenericsMarkets & MarketingPatentsProductionResearch

Indian Pharma growth outpaces rivals, but must embrace innovation

12-03-2013

Ranking among the top five globally by production volume, the Indian pharmaceutical market at present…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProductionResearch

Sagent Pharma launches generic Zometa in USA; amends supply deal with Actavis

07-03-2013

Privately-held US specialty pharmaceutical company Sagent Pharmaceuticals has announced the approval…

ActavisGenericsMarkets & MarketingNorth AmericaNovartisOncologyProductionSagent PharmaceuticalsZometa

China now one of the world's largest heparin API producers and exporters; report

13-01-2013

China, abundant in heparin raw materials, has become one of the world's largest heparin API producers…

Asia-PacificCardio-vascularGenericsheparinMarkets & MarketingPharmaceuticalProduction

Australia's pharma sector a net importer but also one of its largest high-tech exporters

13-01-2013

The pharmaceutical product manufacturing industry in Australia is dominated by major global pharmaceutical…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProduction

Ukrainian government threatens to impose ban on imports of foreign drugs

06-12-2012

The Ukrainian government is considering imposing a ban on the imports of up to 136 drugs to the country,…

EuropeGenericsMarkets & MarketingPharmaceuticalProductionRegulation

"India Pharma Inc" gearing up for the next level of growth

05-11-2012

Indian pharmaceutical companies will have to rethink business strategy in the light of several interventions…

Asia-PacificGenericsHealthcareMarkets & MarketingPharmaceuticalPricingProductionRegulation

Australian Pharma sees opportunities in govt "Asian Century" report

30-10-2012

The government's Australia in the Asian Century report, released this week, highlights the opportunity…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalProductionResearch

India, WHO and PSM India to collaborate to curb spurious and sub-standard medicines

10-09-2012

At an international workshop in New Delhi, it was announced that the Indian government, the World Health…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalProductionRegulation

Hospira to acquire Orchid API production and R&D facility

30-08-2012

US injectable generic drugs specialist Hospira (NYSE: HSP) has reached an agreement to acquire an active…

GenericsHospiraMarkets & MarketingOrchid Chemicals & PharmaceuticalsProductionResearch

Pfizer teams up with Mylan to drive generics business in Japan

23-08-2012

Global pharma behemoth Pfizer (NYSE: OFE) and generics drug major Mylan (Nasdaq: MYL) have signed a definitive…

Asia-PacificGenericsMarkets & MarketingMylan LaboratoriesPfizerProduction

South Africa Pharma industry risk review

09-08-2012

The South African office of Coface, an international credit insurer, released its latest industry risk…

GenericsMarkets & MarketingPharmaceuticalProductionRest of the World

Back to top